Mostrar el registro sencillo del ítem
dc.contributor.author
Soleimani, Arshia
dc.contributor.author
Navarro, Alba
dc.contributor.author
Liu, Delong
dc.contributor.author
Herman, Sarah E. M.
dc.contributor.author
Chuang, Shih Sung
dc.contributor.author
Slavutsky, Irma Rosa
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.contributor.author
Narbaitz, Marina
dc.contributor.author
Safah, Hana
dc.contributor.author
Schmieg, John
dc.contributor.author
Lefante, John
dc.contributor.author
Roschewski, Mark
dc.contributor.author
Wilson, Wyndham H.
dc.contributor.author
Wiestner, Adrian
dc.contributor.author
Saba, Nakhle S.
dc.date.available
2023-10-06T14:29:11Z
dc.date.issued
2022-04
dc.identifier.citation
Soleimani, Arshia; Navarro, Alba; Liu, Delong; Herman, Sarah E. M.; Chuang, Shih Sung; et al.; CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage; Taylor & Francis Ltd; Leukemia and Lymphoma; 63; 4; 4-2022; 911-917
dc.identifier.issn
1042-8194
dc.identifier.uri
http://hdl.handle.net/11336/214348
dc.description.abstract
Conventionally, mantle cell lymphoma (MCL) is an aggressive CD5-positive B-cell malignancy with poor prognosis and limited survival. However, a small subset of patients presents with indolent disease and can be managed on a ‘watch and wait’ approach. CD5-negative MCL has recently been recognized as a more favorable variant of MCL, but its clinical and biological implications remain ill-defined. We performed the most extensive review to-date of all reported cases of CD5-negative MCL and included unpublished cases diagnosed at our institutions to further characterize this disease subset. Based on our analysis of 356 cases of CD5-negative MCL, we conclude that median overall survival exceeds 14 years and is independent of favorable prognostic markers such as leukemic non-nodal disease, absence of SOX11, and low Ki-67.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Taylor & Francis Ltd
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
LYMPHOCYTES
dc.subject
LYMPHOMA AND HODGKIN DISEASE
dc.subject
PROGNOSTICATION
dc.subject.classification
Patología
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Medicina Básica
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2023-07-14T20:22:43Z
dc.journal.volume
63
dc.journal.number
4
dc.journal.pagination
911-917
dc.journal.pais
Reino Unido
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.journal.ciudad
Londres
dc.description.fil
Fil: Soleimani, Arshia. University of Maryland; Estados Unidos
dc.description.fil
Fil: Navarro, Alba. Universidad de Barcelona; España
dc.description.fil
Fil: Liu, Delong. National Institutes of Health; Estados Unidos
dc.description.fil
Fil: Herman, Sarah E. M.. National Institutes of Health; Estados Unidos
dc.description.fil
Fil: Chuang, Shih Sung. Chi-Mei Medical Center; China
dc.description.fil
Fil: Slavutsky, Irma Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
dc.description.fil
Fil: Narbaitz, Marina. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex"; Argentina
dc.description.fil
Fil: Safah, Hana. University of Tulane; Estados Unidos
dc.description.fil
Fil: Schmieg, John. University of Tulane; Estados Unidos
dc.description.fil
Fil: Lefante, John. University of Tulane; Estados Unidos
dc.description.fil
Fil: Roschewski, Mark. National Institutes of Health; Estados Unidos
dc.description.fil
Fil: Wilson, Wyndham H.. National Institutes of Health; Estados Unidos
dc.description.fil
Fil: Wiestner, Adrian. National Institutes of Health; Estados Unidos
dc.description.fil
Fil: Saba, Nakhle S.. University of Tulane; Estados Unidos
dc.journal.title
Leukemia and Lymphoma
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/abs/10.1080/10428194.2021.2002317
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/10428194.2021.2002317
Archivos asociados